The timeline for the Multidisciplinary Association for Psychedelic Studies (MAPS...
CARsgen Therapeutics, a Chinese biotech company, is facing a significant setback...
A probe conducted by the British Medical Journal (BMJ) has provided insight into...
In a major move, the Novo Nordisk Foundation is allocating $260 million to pione...
Checkpoint Therapeutics, headquartered in Waltham, Massachusetts, recently encou...
Pharvaris has reported a significant breakthrough in the treatment of hereditary...
Patients taking Eli Lilly’s weight loss drug Zepbound faced a substantial weight...
A notable development has occurred in the initial treatment of colorectal cancer...
In response to the FDA’s recent safety review of approved CAR-T therapies, Posei...
NeuroOne has now received another agency nod that expands upon the capabilities ...
In a move that marks a significant advancement in the treatment of sickle cell d...
In a recent development, scientists have brought science fiction to life by crea...
In the highly competitive landscape of BTK inhibitors for blood cancer treatment...
Merus, a biopharmaceutical company, confronted a significant setback following a...
Merck KGaA’s foray into the competitive BTK inhibitor space has hit a roadblock,...
Roche has made a resounding entry into the obesity market with a whopping upfron...